Those looking for a feature-rich board but balk at the price of the halo-tier boards will find plenty to like with the MSI ...

ASRock B760I Lightning Despite Intel launching a new CPU socket, motherboard chipset, and a full range of processors (Core ...

Pre-orders are now open for MSI's Claw 7 AI+ and 8 AI+. The successors of the handheld gaming PC the company released in March are equipped with Intel's new Core Ultra 7 258V SoC. The Verge notes ...

It has taken a while, but MSI has finally fully unveiled its new flagship gaming handheld and Steam Deck rival, the MSI Claw 8 AI+, months after first teasing the new device. Not only that ...

MSI has just unveiled two next-gen gaming handhelds, the MSI Claw 8 AI+ and the Claw 7 AI+. A follow-up to the original MSI claw that failed to make much of a splash, these two mini PCs are ...

Finding the best gaming motherboard ... complete with heatsinks. This board isn’t cheap, but it’s a great foundation for a high-end AMD PC. Read our full MSI MPG X870E Carbon WiFi review.

The first MSI Claw handheld gaming PC wasn’t very well received when it launched earlier this year as the first (and only) model in the space to feature an Intel Meteor Lake processor and Intel ...

The MSI Claw 8 AI+ and MSI Claw 7 AI+ are MSI's second-gen gaming handhelds Both handhelds are powered by the Intel Core Ultra 7 258V with Intel Arc Xe2 graphics Preorder the MSI Claw 8 AI+ and ...

MSI has revealed new versions of its Claw handheld gaming PC, which will be available in seven- and eight-inch models. Pricing starts at $799 for the Claw 7 AI+ and $899 for the Claw 8 AI+.

MSI has officially launched its next-generation gaming handhelds, the Claw 8 AI+ and Claw 7 AI+. These devices bring the latest Intel Core Ultra 7 processors, enhanced battery life, and thoughtful ...

MSI has officially announced its next crack at handheld gaming is here with the Lunar Lake-powered MSI Claw 7 AI Plus and MSI Claw 8 AI Plus. The two Windows-based handhelds come with 32GB of RAM ...

Jemperli received FDA breakthrough therapy designation for locally advanced dMMR/MSI-H rectal cancer, following a Fast Track designation in January 2023. The designation aims to expedite development ...